BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Biomedical Advanced Research & Development Authority (BARDA) Accelerator Network Collaborative Virtual Series
Event | 07. 01. 2022
Art Pappas will be participating in BARDA's Accelerator Network Collaborative Virtual Series panel discussion titled "Scale your Company via Strategic Partnerships & Venture Financing" on July 1st from 12:00-1:30 PM EDT.
